Skip to content

13F-HR filed by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-15, with 33 holding rows worth $260,578,000.

Accession
0001144204-15-031238
Filed
2015-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 33 entries on the cover page, a total value of $260,578,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $260,578,000 with VALUE read as thousands by filing date, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMICUS THERAPEUTICS INC03152W109COM4,211,399$45,820,000thousands by filing date
Lion Biotechnologies53619R102COM2,149,907$26,035,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK2,214,043$25,594,000thousands by filing date
CELGENE CORP151020904COM148,800$17,154,000thousands by filing date
PERNIX THERAPEUTICS HOLDINGS71426V108COM1,395,167$14,914,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM475,015$11,006,000thousands by filing date
AGENUS INC00847G705COM NEW2,047,971$10,506,000thousands by filing date
EMERGENT BIOSOLUTIONS INC29089Q105COM330,635$9,509,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM320,867$9,408,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2461,499$8,445,000thousands by filing date
TARO PHARMACEUTICAL INDS LTDM8737E108SHS53,800$7,587,000thousands by filing date
ONCOTHYREON INC682324108COM4,491,636$7,321,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK44,000$7,255,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM475,000$6,873,000thousands by filing date
IGI LABORATORIES INC449575109COM720,908$5,883,000thousands by filing date
UNIQURE NVN90064101SHS226,456$5,507,000thousands by filing date
TONIX PHARMACEUTICALS HOLDING890260201COM NEW755,300$4,773,000thousands by filing date
VERICEL CORP92346J108COM1,058,820$3,918,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON215,705$3,878,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM244,199$3,829,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock160,697$3,234,000thousands by filing date
EXELIXIS INC30161QAC8NOTE 4.250% 8/14,250,000$3,234,000thousands by filing dateprincipal
CHEMOCENTRYX INC16383L106COM323,607$2,443,000thousands by filing date
THERAPEUTICSMD INC88338N107COM392,000$2,372,000thousands by filing date
CORONADO BIOSCIENCES INC21976U109COM600,000$2,310,000thousands by filing date
TROVAGENE INC897238309COM323,728$2,205,000thousands by filing date
IGNYTA INC451731103COM200,772$1,998,000thousands by filing date
Innocoll45780Q103SPONDS ADR225,000$1,689,000thousands by filing date
HEAT BIOLOGICS INC42237K102COM260,000$1,654,000thousands by filing date
BIOLASE INC090911108COMMON STOCK690,000$1,394,000thousands by filing date
TARGACEPT INC87611R306COM466,297$1,385,000thousands by filing date
CELLECTIS ADS15117K103COM30,000$1,037,000thousands by filing date
ALIMERA SCIENCES INC016259103COM81,372$408,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001144204-15-031238this filing2015-05-15acceptance time not in the bulk data set